VIR BIOTECHNOLOGY INC's ticker is and the CUSIP is 92764N952. A total of 5 filers reported holding VIR BIOTECHNOLOGY INC in Q2 2022. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2024 | $541,120 | -19.1% | 60,800 | -7.9% | 0.00% | – |
Q1 2024 | $668,580 | +6.5% | 66,000 | +5.8% | 0.00% | – |
Q4 2023 | $627,744 | -86.0% | 62,400 | -65.8% | 0.00% | -100.0% |
Q2 2023 | $4,479,178 | +843.6% | 182,600 | +795.1% | 0.00% | – |
Q1 2023 | $474,708 | -54.6% | 20,400 | -50.6% | 0.00% | – |
Q4 2022 | $1,045,303 | -23.6% | 41,300 | -41.8% | 0.00% | -100.0% |
Q3 2022 | $1,369,000 | +21.0% | 71,000 | +59.9% | 0.00% | – |
Q2 2022 | $1,131,000 | – | 44,400 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
JPMORGAN CHASE & CO | 79,800 | $1,857,000 | 0.00% |
SIMPLEX TRADING, LLC | 4,500 | $104 | 0.00% |
GROUP ONE TRADING LLC | 300 | $6,981 | 0.00% |
JANE STREET GROUP, LLC | 20,400 | $474,708 | 0.00% |
CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |